Clinical Trial Update: Safety, Tolerability, PK, and Analgesic Effect of INL-001 in Children Following Open Inguinal Hernia Repair [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating INL-001 for safety, tolerability, pharmacokinetics, and analgesic effect in children after open inguinal hernia repair.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inguinal Hernia
• Postoperative Pain

Drugs mentioned

• INL-001

Snippet

Sponsor: Innocoll | Conditions: Inguinal Hernia, Postoperative Pain | Phase 3 | Status: UNKNOWN